Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-B )

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT06492265

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
  • Yongjun Wang Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06492265
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06492265. Randomized; single masking; primary purpose treatment. Start 2024-08-04 (actual); primary completion 2025-02-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-B )
Condition
Ischemic Stroke, Acute
Intervention (Combination product)
Emergency Stroke Unit based on 0.23-T MRI
Intervention (Combination product)
Standard stroke unit adherent to guidelines
Lead sponsor
Yongjun Wang (class: other)

Record details

Record id
cardio:ct-nct06492265
Content hash
a3b9a2c01bac5c761245b394ee2f08788b01d0921c525ec9dd224fd39feadddb